BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19922830)

  • 1. [(18)F-FDG PET-CT and respiratory synchronization: effect in the detection and catalogation of pulmonary lesions].
    García Vicente AM; Soriano Castrejón A; Talavera Rubio P; Poblete García VM; Palomar Muñoz A; Cepedello Boiso I; González García B; Cordero García JM; Bellón Guardia M; Pilkington Woll JP
    Rev Esp Med Nucl; 2009; 28(4):181-7. PubMed ID: 19922830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
    Farid K; Poullias X; Alifano M; Regnard JF; Servois V; Caillat-Vigneron N; Petras S
    Nucl Med Commun; 2015 Jul; 36(7):722-7. PubMed ID: 25793929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications.
    García Vicente AM; Soriano Castrejón AM; Talavera Rubio MP; León Martín AA; Palomar Muñoz AM; Pilkington Woll JP; Poblete García VM
    Ann Nucl Med; 2010 Apr; 24(3):207-14. PubMed ID: 20177834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of 4-dimensional 18F-FDG PET/CT in the classification of pulmonary lesions.
    García Vicente AM; Castrejón AS; León Martín AA; García BG; Pilkington Woll JP; Muñoz AP
    J Nucl Med Technol; 2011 Jun; 39(2):91-9. PubMed ID: 21565957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans.
    Aristophanous M; Yong Y; Yap JT; Killoran JH; Allen AM; Berbeco RI; Chen AB
    Radiother Oncol; 2012 Mar; 102(3):377-82. PubMed ID: 22265731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET motion compensation for radiation therapy using a CT-based mid-position motion model: methodology and clinical evaluation.
    Kruis MF; van de Kamer JB; Houweling AC; Sonke JJ; Belderbos JS; van Herk M
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):394-400. PubMed ID: 23910710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of an additional inspiration CT scan on the conventional protocol of the ¹⁸F-FDG PET-CT in the detection of small pulmonary nodes].
    García JR; Lozano P; Soler M; Alvarez Moro FJ; Fuertes S; Arribas C; Riera E; Lomeña F
    Rev Esp Med Nucl; 2010; 29(6):285-8. PubMed ID: 20702003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study.
    Crivellaro C; De Ponti E; Elisei F; Morzenti S; Picchio M; Bettinardi V; Versari A; Fioroni F; Dziuk M; Tkaczewski K; Ahond-Vionnet R; Nodari G; Todde S; Landoni C; Guerra L
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):102-109. PubMed ID: 28825125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases.
    Siva S; Callahan JW; Kron T; Chesson B; Barnett SA; Macmanus MP; Hicks RJ; Ball DL
    Acta Oncol; 2015; 54(8):1105-12. PubMed ID: 25833329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
    Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory-gated 18F-FDG PET imaging in lung cancer: effects on sensitivity and specificity.
    Daouk J; Leloire M; Fin L; Bailly P; Morvan J; El Esper I; Saidi L; Moullart V; François G; Jounieaux V; Meyer ME
    Acta Radiol; 2011 Jul; 52(6):651-7. PubMed ID: 21511870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
    Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
    Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Spatial Alignment in PET/CT Using Amplitude-Based Respiration-Gated PET and Respiration-Triggered CT.
    van der Vos CS; Grootjans W; Osborne DR; Meeuwis AP; Hamill JJ; Acuff S; de Geus-Oei LF; Visser EP
    J Nucl Med; 2015 Dec; 56(12):1817-22. PubMed ID: 26383151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating benign and malignant pulmonary lesions with FDG-PET.
    Yang SN; Liang JA; Lin FJ; Kwan AS; Kao CH; Shen YY
    Anticancer Res; 2001; 21(6A):4153-7. PubMed ID: 11911310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
    Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology.
    Karam M; Roberts-Klein S; Shet N; Chang J; Feustel P
    J Nucl Med; 2008 Sep; 49(9):1429-36. PubMed ID: 18765585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.